GERN Q4 2022 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$103,000-90.1% YoY

Gross Profit

-$27M-26070.9% margin

Operating Income

-$42M-40729.1% margin

Net Income

-$43M-41393.2% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-65.3%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$191M

Total Liabilities

$111M

Stockholders' Equity

$80M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$103,000	$1M	-90.1%
Gross Profit	-$27M	-$22M	-22.5%
Operating Income	-$42M	-$31M	-35.4%
Net Income	-$43M	-$32M	-33.2%